Correlation Between Kymera Therapeutics and Tff Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Kymera Therapeutics and Tff Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kymera Therapeutics and Tff Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kymera Therapeutics and Tff Pharmaceuticals, you can compare the effects of market volatilities on Kymera Therapeutics and Tff Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kymera Therapeutics with a short position of Tff Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kymera Therapeutics and Tff Pharmaceuticals.

Diversification Opportunities for Kymera Therapeutics and Tff Pharmaceuticals

0.36

Correlation Coefficient

Kymera Therapeutics  Tff Pharmaceuticals

Weak diversification

The 3 months correlation between Kymera and Tff is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Kymera Therapeutics and Tff Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tff Pharmaceuticals and Kymera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kymera Therapeutics are associated (or correlated) with Tff Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tff Pharmaceuticals has no effect on the direction of Kymera Therapeutics i.e., Kymera Therapeutics and Tff Pharmaceuticals go up and down completely randomly.

Pair Corralation between Kymera Therapeutics and Tff Pharmaceuticals

Given the investment horizon of 90 days Kymera Therapeutics is expected to generate 0.25 times more return on investment than Tff Pharmaceuticals. However, Kymera Therapeutics is 3.98 times less risky than Tff Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Tff Pharmaceuticals is currently generating about -0.11 per unit of risk. If you would invest  4,632  in Kymera Therapeutics on September 2, 2024 and sell it today you would earn a total of  53.00  from holding Kymera Therapeutics or generate 1.14% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Kymera Therapeutics  vs.  Tff Pharmaceuticals

Kymera Therapeutics

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Kymera Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable primary indicators, Kymera Therapeutics is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Tff Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tff Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Kymera Therapeutics and Tff Pharmaceuticals

The main advantage of trading using opposite Kymera Therapeutics and Tff Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kymera Therapeutics position performs unexpectedly, Tff Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tff Pharmaceuticals will offset losses from the drop in Tff Pharmaceuticals' long position.

The idea behind Kymera Therapeutics and Tff Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.